GlassScriptPhysician profile
Cheryl A Millender
NPI 1538365648
$3,333.29
in general payments reported to CMS, 2019-2025
28 companies · $904 in 2025
The $904 reported for 2025 was more than what 95% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $603 · 2022: $554 · 2023: $756 · 2024: $516 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,003.77 |
| Education | $172.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $467.72 | 2021-2025 | |
| Astellas Pharma US INC | $398.75 | 2022-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $365.20 | 2023-2025 | Myfembree |
| Millicent US INC | $316.42 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Abbvie INC. | $293.77 | 2021-2023 | |
| Pfizer INC. | $250.75 | 2021-2025 | |
| Organon LLC | $185.74 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $169.34 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $123.82 | 2021-2022 | |
| Exact Sciences Corporation | $109.17 | 2023-2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $86.67 | 2022-2025 | Stratafix, Echelon; Endopath, Surgicel Nu-Knit |
| Evofem Biosciences, INC. | $83.96 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.56 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.53 | 2022-2023 | Xifaxan |
| Sage Therapeutics, LLC | $43.24 | 2025 | Zurzuvae |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $41.56 | 2022-2024 | |
| Ascend Therapeutics US, LLC | $33.76 | 2021-2023 | |
| Lupin INC. | $31.79 | 2021 | |
| Hologic Sales and Service, LLC | $30.17 | 2022 | |
| Daiichi Sankyo INC. | $28.14 | 2024 | Injectafer |
| Therapeuticsmd, INC. | $28.04 | 2021-2022 | |
| Avion Pharmaceuticals | $25.25 | 2021 | |
| Mylan Pharmaceuticals INC. | $23.55 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.75 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $21.04 | 2023 | Vivjoa |
| Scynexis, INC. | $20.71 | 2022 | |
| Minerva Surgical, INC | $16.46 | 2024 | |
| Merck Sharp & Dohme LLC | $13.43 | 2023 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Millender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.